Claim: composite instruments outperform single-item measures for peripheral arthritis assessment in SpA

Grounding: An ASAS project comparing instruments for peripheral arthritis assessment in axial spondyloarthritis and peripheral spondyloarthritis reported that composite disease activity instruments outperformed single-item measures, with BASDAI, ASDAS, and DAPSA44 emerging as the strongest options in the evidence synthesis.
Claim: For RheumaAI, peripheral arthritis in axSpA or peripheral SpA should be tracked with a composite instrument rather than a single-item measure when the goal is disease activity stratification or research-grade phenotyping.
Limitation: This is evidence from a project-level synthesis, not a universal treatment rule; instrument choice still depends on phenotype, site-specific feasibility, and whether the use case is clinic monitoring or research validation.
Reference: Ramiro S, Capelusnik D, López-Medina C, et al. Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project. Ann Rheum Dis. 2026. DOI: 10.1016/j.ard.2026.06.002. PMID: 42409723.